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Scientiﬁc conferences fulﬁl many roles, but one of the most
mportant ones is that they help shape the direction in which a sci-
ntiﬁc discipline grows by promoting person-to-person exchanges
f information, ideas and constructive criticisms between scientists
rom different backgrounds. This interaction also helps to iden-
ify areas of controversy and promotes efforts to address and, it is
oped, resolve them. This year is the 30th anniversary of the pub-
ication of the ﬁrst practical description of the polymerase chain
eaction [1], arguably one of the simplest and the most widely used
olecular technology. It also sees the 7th instalment of the Freis-
ng PCR meetings (http://www.qpcr-ngs-2015.net/), which are the
ongest established, continuous and most inﬂuential conferences in
his ﬁeld and have provided a looking glass for conceptual and tech-
ical innovation as well as practical applications of PCR-associated
ethods.
The ﬁrst of this conference series took place in March 2004,
 propitious time for such a conference, eleven years after Russ
iguchi published his paper describing the use of real-time quan-
itative PCR (qPCR) [2] and nine years after the publication of
olecular beacons [3] and a 5′ hydrolysis-based qPCR assay [4].
he meeting was organised, as it still is, by Michael Pfafﬂ, one of
he founding editors of Biomolecular Detection and Quantiﬁcation
BDQ). Michael had dabbled with competitive reverse transcription
RT)-PCR, preparing synthetic competitive templates and detec-
ing PCR ampliﬁcation products using HPLC-UV to quantify IGF-1
RNA levels in bovines [5]. But in 2001 he published his seminal
new mathematical model for relative quantiﬁcation in real-time
T-PCR” [6], which has been cited over 14,000 times in the peer-
eviewed literature. This was followed by another highly cited
ublication, which introduced the relative expression software tool
REST) for group-wise comparison and statistical analysis of rela-
ive expression results in qPCR [7]. Meanwhile another founding
ditor of BDQ had long since established his reputation as one of
he foremost innovators and though leaders in the ﬁeld. Carl Wit-
wer described a new type of thermal cycler that was based on
eat transfer with air to samples in sealed capillary tubes, sim-
lar to a “recirculating hair dryer” [8]. He followed this up with
ttp://dx.doi.org/10.1016/j.bdq.2015.01.001
214-7535/© 2015 Published by Elsevier GmbH. This is an open access article under the Ca rapid cycling protocol that introduced the concept of a 15 min
PCR [9], something he has recently bested with a 15 s PCR [10].
In fact, by 2004 a considerable amount of Carl’s research effort
had gone into increasing the efﬁciency of the PCR and optimising
instruments, time and temperature parameters [11–15] as well as
ﬁnding suitable applications for all these improvements, for exam-
ple fusion transcript detection in leukaemia [16], multiplexing with
hybridisation probes for genotyping [17] and melt curve analysis
for the detection of chromosomal translocations in mantle cell lym-
phoma [18], to name but a few. Another pioneer of qPCR was Mikael
Kubista, who by this time had established his reputation with the
invention of light up probes [19], novel ﬂuorescent dyes suitable
for qPCR [20] and had also turned his attention to the question of
how to deal with PCR assays with different efﬁciencies in the expo-
nential phase of the reaction [21]. Together with his then student
Anders Stahlberg he published two insightful papers on the vari-
ability of the reverse transcription step [22,23], which underlies
many molecular assays and was  the ﬁrst empirical demonstra-
tion of the enzyme, target and concentration-dependence of cDNA
synthesis efﬁciency. By 2004 Jo Vandesompele had published his
ground-breaking GeNorm paper [24], which has been cited over
8000 times and provided an ingenious solution to the problem of
how to select appropriate reference genes for the normalisation of
RNA data. He had also started to consider approaches to improving
and simplifying primer and probe design and announced details of
the ﬁrst public database application for the storage and retrieval of
validated qPCR primer and probe sequence records [25].
By the time of the ﬁrst Freising meeting, the advantages of qPCR
were beginning to be appreciated, a development reﬂected in the
number of papers published by the end of 2003 that made use of this
technology (Fig. 1). The combination of reverse transcription and
PCR into RT-qPCR was also utilised from the very beginning and
followed the same curve, albeit at a much lower level. However,
whilst there were comparatively few technical problems associ-
ated with DNA-targeted quantitative PCR, by 2004 it was becoming
clear that reliable RT-qPCR assays were a different matter: results
depended on RNA quality, consistent RT conditions, appropriate
normalisation and the application of suitable statistical method-
ologies [26,27]. The uncertainty arising from these four issues with
regards to biological or clinical relevance of many RT-qPCR results
were discussed at that ﬁrst meeting and they have continued to
play a central role in every one of the subsequent meetings held
in September 2005 (2nd), March 2007 (3rd), March 2009 (4th),
March/April 2011 (5th), March 2013 (6th) and undoubtedly will
do so at the 7th.
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Publications utilising qPCR published by the time of the ﬁrst Freising meeting
(1996–12/2003). Results from a PubMed search for the terms (1) “real-time PCR” or
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Fig. 2. Publications utilising qPCR published from 2004 to 2014. Results from a
PubMed search for the terms (1) “real-time PCR” or “realtime PCR” or “real time
with rival faster, cheaper and more accurate technologies. Together
with the continuous improvement of bioinformatics tools, this is
allowing smaller research groups to consider more routine use ofrealtime PCR” or “real time PCR” or qPCR and (2) “real-time PCR” or “realtime PCR”
r  “real time PCR” or qPCR and “reverse transcription” were plotted against the year
he publication appeared.
The meeting of minds at the various Freising conferences
ertainly paved the way for the publication of the minimum infor-
ation for the publication of quantitative PCR (MIQE) guidelines,
hich appeared in 2009 [28]. These arose out of the conviction of a
orldwide group of PCR practitioners that there were serious issues
ith the way qPCR experiments in general, but RT-qPCR experi-
ents in particular were being performed. A survey of RT-qPCR
ractices taken at the 2005 London qPCR meeting had revealed
xtensive variation in assay design, validation and analysis, with
ittle regard for reporting experimental detail or paying attention
o the importance of the four areas mentioned previously [29]. The
IQE guidelines had the aim of establishing best practice guidelines
or the design of qPCR experiments and the subsequent transpar-
nt reporting of experimental detail. The guidelines have certainly
een successful in so far as that there is a universal awareness of
heir existence, with all major suppliers of qPCR instruments and
eagents committed to promoting their use. However, recent sur-
eys of qPCR-based papers continue to ﬁnd that the vast majority
f papers are signiﬁcantly ﬂawed in the reporting of experimen-
al detail and often use inappropriate methods long since shown
o be invalid [30–32]. The most obvious example is the contin-
ed, near-universal use of single reference genes, which for precise
pplications are not able to generate reliable and biologically mean-
ngful results [24,33–36].
Inhibition is one key area that affects signiﬁcantly the reliability
f a (RT)-PCR assay, but is often ignored. Inhibition affects both
everse transcriptases [37] and thermostable DNA polymerases
38] and some polymerases are more susceptible to inhibition than
thers [39]. This was recognised early on and there have been
umerous reports detailing the effects of many different compo-
ents on the reliability of (RT)-PCR results [40–52] and proposing
olutions that overcome [21,49,53–60] or at least detect [61] that
nhibition. One worrying aspect of inhibition is that it does not
ffect all PCR reactions to the same extent, i.e. some assays are
ore susceptible to inhibition than others [62]. This has important
mplications for any gene expression experiment, as a differential
ffect of inhibition on target genes of interest as well as the ref-
rence genes will result in incorrect results and is also another
ource of error for PCR-based molecular diagnostic assays. Unfor-
unately, inhibition testing is not at all common [32] and there is an
rgent need to consider inhibition compatibility when conducting
CR analyses [62].
An interesting development is that 2014 is the ﬁrst year in which
here has been a reduction in the number of qPCR as well as RT-
PCR papers published (Fig. 2). It will be interesting to see whetherPCR” or qPCR and (2) “real-time PCR” or “realtime PCR” or “real time PCR” or qPCR
and “reverse transcription” were plotted against the year the publication appeared.
this is a blip or the beginning of an impact exerted by a combi-
nation of next generation sequencing and digital PCR. The latter is
certainly beginning to take off, but is currently where qPCR was  in
2000 (Fig. 3).
Ironically, dPCR precedes qPCR [63] but had to await the devel-
opment of suitable instrumentation to become a serious competitor
to qPCR. It allows very precise measurement of DNA molecules by
partitioning a limiting dilution of DNA into a succession of indi-
vidual PCR reactions. DNA templates are randomly distributed into
sub-reactions, termed partitions, and as long as there are negative
partitions, Poisson statistics can be used to measure the quantities
of DNA present for a given proportion of positive partitions (Fig. 4).
There is no longer a need for calibration curves [64] and dPCR may
even be less susceptible to inhibitors [65]. The publication of the
MIQE guidelines for dPCR [66] might just help avoid many of the
pitfalls that have opened up for qPCR, especially as it has become
clear that many of the issues faced by (RT)-qPCR are also issues for
(RT)-dPCR [64,67–69].
Next generation high throughput sequencing (NGS) has become
an increasingly important element of the Freising meetings, not
surprisingly given its companion status with PCR and its impact
on biological and clinical applications [70]. There has been rapid
progress in sequencing technologies, with less efﬁcient, competi-
tive or more expensive methods dropping out and being replacedFig. 3. Publications utilising dPCR. Results from a PubMed search for the term “dig-
ital  PCR” were plotted against the year the publication appeared.
Editorial / Biomolecular Detection and Quantiﬁcation 3 (2015) A1–A5 A3
F rreus a
w ent fo
p ol [77
N
r
n
t
o
m
p
m
A
i
m
A
p
m
t
l
n
t
g
c
c
f
tig. 4. dPCR analysis of Aspergillus DNA. DNA concentrations of A. fumigatus,  A. te
ere  diluted to 40 fg/l, and analysed on a Formulatrix Constellation dPCR instrum
rimers  targeting the 18S rDNA repeat were used, together with a published protoc
GS. Indeed, over the course of the next decade this is likely to
esult in the replacement of rival high-throughput technologies.
As always, of course, there are issues with NGS [71,72] and, again
ot surprisingly, these are often associated with whole transcrip-
ome (RNAseq) applications especially when applied to the analysis
f low levels of RNA [73,74].
Unambiguous assembly into a single contig of repetitive ele-
ents that are longer than sequencing read-length is another
roblem with short read NGS technology. Instead, one is left with
ultiple contigs that leave gaps in whole genome assemblies.
gain technology is coming to the rescue and DNA sequenc-
ng using nanopore technology shows promise as an alternative
ethod for producing long-read sequence data more cheaply [75].
 recent report uses this technology to solve the structure of a com-
lex antibiotic resistance island in Salmonella typhi [76], achieving
edian read lengths of 6 kb with an accuracy of 72%. Promisingly,
his was achieved without any attempts made to optimise read
ength, which was determined by the length of the input DNA,
ot the chemistry. The authors rightly conclude by saying that this
ype of technology has the potential to create a paradigm shift in
enomics, bringing low cost, long-read sequencing to the nonspe-
ialist laboratory.The increasing focus on accurate as well as precise quantiﬁ-
ation of nucleic acids, proteins and small molecules requires a
orum for the exchange of ideas, concepts, tools and applications
hat reaches way beyond the scope of a scientiﬁc meeting, nond A. ﬂavus preparations were measured on a Nanodrop instrument and samples
llowing 40 cycles of PCR with Agilent Brilliant III mastermix. Hydrolysis probes and
]. (A) A. fumigatus. (B) A. terreus. (C) A. ﬂavus.
matter how well organised, attended and inﬂuential. BDQ hopes
to provide a platform for precisely this purpose. BDQ is an open
access, peer-reviewed international journal dedicated to champi-
oning excellence in molecular study design, measurement, data
analysis and reporting. Its focus is on the application of qualitative
and quantitative molecular methodologies to all areas of clinical
and life sciences. The journal has two  main aims:
• to provide a forum for discussion and recommendation of
guidelines designed to improve the accuracy of molecular mea-
surement, its data analysis and the transparency of its subsequent
reporting;
• to publish molecular biology based studies that adhere to best
practice guidelines, both current and future.
BDQ was established by a group of scientists based on their
experience developing and publishing the MIQE and digital MIQE
guidelines. The deliberately broad scope of the journal covers clini-
cal areas such as cancer, epigenetics, metagenomics, and infectious
diseases as well non clinical subjects including environmental sci-
ences, microbiology and food science. BDQ revolves around the
common theme of promoting excellence in molecular measure-
ment and its data analysis. It will serve as a repository for sharing
key ﬁndings across what may  otherwise be disparate specialties.
We look forward to receiving manuscripts from the attendees
of this year’s conference and hope that BDQ will become the
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ournal of choice for an increasing number of scientiﬁc publications
edicated to transparency of reporting, excellence of protocols and
igniﬁcance of results.
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